C07D 253/08
Condensed with carbocyclic rings or ring systems
Official title: condensed with carbocyclic rings or ring systems
C07D253/08 (Condensed with carbocyclic rings or ring systems) appears on 144 US grants and 116 published applications in this corpus.
Search patents in C07D- Granted patents
- 144
- Published applications
- 116
- Assignees
- 104
- Inventors
- 487
- Latest grant
- 14 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 2 | 0 |
| 1978 | 2 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 6 | 0 |
| 2000 | 0 | 0 |
| 2001 | 3 | 0 |
| 2002 | 6 | 4 |
| 2003 | 2 | 3 |
| 2004 | 3 | 6 |
| 2005 | 4 | 10 |
| 2006 | 3 | 5 |
| 2007 | 3 | 5 |
| 2008 | 3 | 6 |
| 2009 | 1 | 5 |
| 2010 | 5 | 6 |
| 2011 | 4 | 5 |
| 2012 | 1 | 4 |
| 2013 | 7 | 9 |
| 2014 | 7 | 5 |
| 2015 | 7 | 3 |
| 2016 | 6 | 11 |
| 2017 | 7 | 9 |
| 2018 | 4 | 4 |
| 2019 | 2 | 2 |
| 2020 | 4 | 5 |
| 2021 | 5 | 5 |
| 2022 | 1 | 1 |
| 2023 | 1 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 2 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Markers, conjugates, compositions and methods for hypoxia imaging, mapping, and therapy14 Apr 2026US 12,600,742 B2WWIKY Biosciences Inc.
- Substituted benzotriazinone metabolites of a GPR139 agonist24 Feb 2026US 12,559,465 B2Takeda Pharmaceutical Company Limited
- Organic compounds and organic light emitting display device using the same16 Dec 2025US 12,497,369 B2Lapto Co., Ltd.
- Organic compound, organic light emitting diode and organic light emitting device including the compound23 May 2023US 11,655,219 B2LG Display Co., Ltd.
- Compound and preparation and application thereof15 Feb 2022US 11,247,997 B2Institute of Chemical Materials of China Academy of Engineering and Physics
- New Coolants, and Preparations Containing Same22 May 2025US 2025/0163006 A1Symrise AG
- 2-substituted thiazole hsd17b13 inhibitors and uses thereof27 Mar 2025US 2025/0100993 A1Inipharm, Inc.
- Substituted benzotriazinone metabolites of a gpr139 agonist20 Jul 2023US 2023/0227416 A1Takeda Pharmaceutical Company Limited
- Bioreductively-activated compounds, their prodrugs, radiopharmaceuticals, the compositions, and their applications in multimodal theranostic management of hypoxia diseases including cancer11 Aug 2022US 2022/0249710 A1The Governors of the University of Alberta
- Organic compounds and organic light emitting display device using the same1 Jul 2021US 2021/0198212 A1Lapto Co., Ltd.
Most cited
By later US patents
- Neprilysin inhibitors51US 9,108,934 B2Theravance Biopharma R&D IP, LLC · 2015
- Aminobutyric acid derivatives49US 6,420,427 B1Ono Pharmaceutical Co., Ltd. · 2002
- Vasculostatic agents and methods of use thereof47US 7,208,493 B2TargeGen, Inc. · 2007
- 1,2,4-Benzotriazine-1,4-di-N-oxide derivatives30US 4,160,833 ACiba-Geigy Corporation · 1979
- Process for preparing 1,2,4-benzotriazine oxides30US 5,175,287 AS R I International · 1992